Organization of the original immunomodulator production and release of the pilot batches of new drug.

11.09.18
|
2016 year

Grant recipient

JSC International research and production holding “Phytochemistry”

Term of realization

from 2016 to 2018

The purpose of the project

is to produce the new original immunomodulator. 

Resulting product of commercialization

Tablets of Arglabin Native with an enteric coating.

Expected results

- to develop experimental-industrial regulations for production of a peroral dosage form of the new immunomodulator;

- to prepare the Act of  deployment into production of the new immunomodulatory drug;

- to set up the serial production of original immunomodulator Arglabin Native in coated tablets for sale;

- to sign promotion agreements with the distribution companies.

Advantages

a low price of the drug as compared to other existing analogues (twice cheaper);

the adequate resource base for substance production.


Contacts

010000, Republic of Kazakhstan, Аstanа, Tauelsizdik av., 41, BC «Silk Way Center», 4 floor

Contact us

We guarantee the confidentiality of your data
Feedback